Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : NVO save search
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons
Published: 2023-11-06 (Crawled : 13:30) - globenewswire.com
NVO | $123.64 -0.21% 1.4M
|
Health Technology
|
| O: 1.69%
H: 1.67%
C: 1.25%
Addressing the Global HIV Challenge: Market for Diagnostics and Therapeutics Plays a Crucial Role in Combating HIV/AIDS
Published: 2023-11-03 (Crawled : 17:00) - prnewswire.com
TRUMF | $16.504 1.7K
|
Health Technology
|
| O: -0.28%
H: 4.55%
C: 0.01%
SNYNF | $92.966 630
|
Health Technology
|
| O: -1.79%
H: 0.0%
C: 0.0%
NVSEF | $93.6375 82K
|
Health Technology
|
| O: -1.88%
H: 3.51%
C: 2.73%
TRUMY | $16.53 31K
|
Manufacturing
|
| O: 3.89%
H: 0.0%
C: -1.74%
TMO | $555.75 -0.38% 380K
|
Health Technology
|
| O: 2.32%
H: 0.0%
C: 0.0%
QGEN | $39.37 -0.76% 330K
|
Health Technology
|
| O: 2.12%
H: 1.06%
C: 0.51%
NVO | $123.64 -0.21% 1.4M
|
Health Technology
|
| O: -2.23%
H: 0.16%
C: -0.52%
NVS | $93.29 -1.19% 530K
|
Health Technology
|
| O: -1.4%
H: 0.42%
C: 0.0%
JNJ | $144.56 -2.05% 4.3M
|
Health Technology
|
| O: 2.15%
H: 0.0%
C: 0.0%
BDX | $232.67 -0.87% 180K
|
Health Technology
|
| O: 1.1%
H: 0.33%
C: 0.07%
SNY | $46.19 0.57% 580K
|
Health Technology
|
| O: -3.04%
H: 0.0%
C: 0.0%
QGEN | $39.37 -0.76% 330K
|
Health Technology
|
| O: 2.12%
H: 1.06%
C: 0.51%
global hiv diagnostics therapeutics market
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons
Published: 2023-11-03 (Crawled : 14:00) - globenewswire.com
NVO | $123.64 -0.21% 1.4M
|
Health Technology
|
| O: -2.23%
H: 0.16%
C: -0.52%
Novo Nordisk's sales increased by 29% in Danish kroner and by 33% at constant exchange rates to DKK 166.4 billion in the first nine months of 2023
Published: 2023-11-02 (Crawled : 07:00) - globenewswire.com
NVO | $123.64 -0.21% 1.4M
|
Health Technology
|
| O: 3.69%
H: 0.96%
C: -0.35%
sales
Novo Nordisk A/S - share repurchase programme
Published: 2023-11-01 (Crawled : 17:00) - globenewswire.com
NVO | $123.64 -0.21% 1.4M
|
Health Technology
|
| O: 0.87%
H: 0.73%
C: 0.28%
repurchase
Medical Segment Dominates, Expected to Reach $70.4 Billion by 2030 in the Global Recombinant DNA Technology Market
Published: 2023-11-01 (Crawled : 01:00) - prnewswire.com
GLAXF | $20.2 510
|
Health Technology
|
| O: -1.62%
H: 0.0%
C: 0.0%
SNYNF | $92.966 630
|
Health Technology
|
| O: 0.94%
H: 2.55%
C: 2.55%
NVSEF | $93.6375 82K
|
Health Technology
|
| O: 2.52%
H: 0.04%
C: 0.04%
NVO | $123.64 -0.21% 1.4M
|
Health Technology
|
| O: 0.87%
H: 0.73%
C: 0.28%
NVS | $93.29 -1.19% 530K
|
Health Technology
|
| O: 0.16%
H: 0.7%
C: 0.57%
GSK | $39.935 -1.4% 900K
|
Health Technology
|
| O: -4.06%
H: 1.9%
C: 0.96%
LLY | $745.04 -0.76% 730K
|
Health Technology
|
| O: -2.76%
H: 0.0%
C: 0.0%
SNY | $46.19 0.57% 580K
|
Health Technology
|
| O: 0.18%
H: 0.0%
C: 0.0%
expected reach global dna medical technology market
MapLight Therapeutics Closes $225 Million Series C Funding Round to Advance Pipeline of Central Nervous System Therapeutics
Published: 2023-10-30 (Crawled : 18:00) - biospace.com/
NVO | $123.64 -0.21% 1.4M
|
Health Technology
|
| O: 3.44%
H: 0.71%
C: -0.33%
pipeline series system therapeutics funding
Vect-Horus Enters Exclusive License Agreement with Novo Nordisk to Develop Targeted Therapeutics
Published: 2023-10-30 (Crawled : 14:00) - biospace.com/
NVO | $123.64 -0.21% 1.4M
|
Health Technology
|
| O: 3.44%
H: 0.71%
C: -0.33%
license therapeutics agreement
Orexo announces changes in the company´s Board of Directors - October 27, 2023
Published: 2023-10-27 (Crawled : 08:00) - biospace.com/
NVO | $123.64 -0.21% 1.4M
|
Health Technology
|
| O: -1.5%
H: 0.78%
C: -0.29%
Orexo announces changes in the company´s Board of Directors
Published: 2023-10-27 (Crawled : 07:00) - prnewswire.com
NVO | $123.64 -0.21% 1.4M
|
Health Technology
|
| O: -1.5%
H: 0.78%
C: -0.29%
EMIS INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Emisphere Technologies, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
Published: 2023-10-26 (Crawled : 01:00) - prnewswire.com
NVO | $123.64 -0.21% 1.4M
|
Health Technology
|
| O: -1.47%
H: 0.22%
C: -0.83%
DMTK 4 | $0.609 -1.77% 32K
|
Health Technology
|
| O: -1.64%
H: 1.67%
C: -1.67%
Global Bleeding Disorders Treatment Market Surpasses $14 Billion in 2022, Expected to Reach $20.3 Billion by 2028
Published: 2023-10-25 (Crawled : 22:00) - prnewswire.com
TAK | $13.235 0.42% 710K
|
Health Technology
|
| O: -4.69%
H: 0.69%
C: -3.18%
NVO | $123.64 -0.21% 1.4M
|
Health Technology
|
| O: -1.47%
H: 0.22%
C: -0.83%
JNJ | $144.56 -2.05% 4.3M
|
Health Technology
|
| O: 0.1%
H: 0.0%
C: 0.0%
SNY | $46.19 0.57% 580K
|
Health Technology
|
| O: 0.09%
H: 0.0%
C: 0.0%
bleeding expected reach disorders treatment global market
Global Generic Drugs Business Analysis Report 2023-2030: Small-molecule Generic Drugs Account for a Lion's Share, Biosimilars Exhibit Fastest Growth
Published: 2023-10-23 (Crawled : 19:00) - prnewswire.com
ENDPQ 6 d | $0.0018 420K
|
n/a
|
| O: -44.44%
H: 60.0%
C: -20.0%
AZNCF | $135.94 770
|
Health Technology
|
| O: 1.37%
H: 1.36%
C: 1.36%
VTRS | $11.15 -1.5% 2.3M
|
Health Technology
|
| O: 0.45%
H: 2.46%
C: 1.67%
NVO | $123.64 -0.21% 1.4M
|
Health Technology
|
| O: -0.79%
H: 1.41%
C: 1.21%
LLY | $745.04 -0.76% 730K
|
Health Technology
|
| O: -0.84%
H: 0.0%
C: 0.0%
BAX | $39.415 -1.56% 640K
|
Health Technology
|
| O: 0.2%
H: 0.9%
C: -1.05%
ABT | $109.02 0.12% 1.7M
|
Health Technology
|
| O: -1.82%
H: 0.0%
C: 0.0%
SNY | $46.19 0.57% 580K
|
Health Technology
|
| O: 0.77%
H: 0.0%
C: 0.0%
AZN | $68.39 -0.5% 1.1M
|
Health Technology
|
| O: 0.38%
H: 2.31%
C: 2.02%
report business global growth
Novo Nordisk A/S - share repurchase programme
Published: 2023-10-23 (Crawled : 13:00) - globenewswire.com
NVO | $123.64 -0.21% 1.4M
|
Health Technology
|
| O: 0.82%
H: 0.87%
C: 0.04%
repurchase
Cytoki Pharma Presents Preclinical Data Demonstrating Weight Reduction and Improved Glucose Control with Lipidated IL-22 at ObesityWeek 2023
Published: 2023-10-16 (Crawled : 19:00) - biospace.com/
NVO | $123.64 -0.21% 1.4M
|
Health Technology
|
| O: -0.84%
H: 0.19%
C: -0.13%
il-22 obesityweek pharma control preclinical
Novo Nordisk A/S – Share repurchase programme
Published: 2023-10-16 (Crawled : 12:00) - globenewswire.com
NVO | $123.64 -0.21% 1.4M
|
Health Technology
|
| O: -0.84%
H: 0.19%
C: -0.13%
repurchase
Novo Nordisk to acquire ocedurenone for uncontrolled hypertension from KBP Biosciences
Published: 2023-10-16 (Crawled : 11:00) - globenewswire.com
NVO | $123.64 -0.21% 1.4M
|
Health Technology
|
| O: -0.84%
H: 0.19%
C: -0.13%
acquire hypertension
Novo Nordisk raises sales and operating profit outlook for 2023
Published: 2023-10-13 (Crawled : 13:00) - globenewswire.com
NVO | $123.64 -0.21% 1.4M
|
Health Technology
|
| O: 1.41%
H: 2.37%
C: 0.54%
sales
Novo Nordisk will stop the once-weekly injectable semaglutide kidney outcomes trial, FLOW, based on interim analysis
Published: 2023-10-10 (Crawled : 21:00) - globenewswire.com
NVO | $123.64 -0.21% 1.4M
|
Health Technology
|
| O: 3.75%
H: 2.82%
C: 2.42%
kidney
The Evolving Market Dynamics of Factor-based Bleeding Disorders: Hemophilia A, Hemophilia B, and Von Willebrand Disease | Key Analysis by DelveInsight
Published: 2023-10-09 (Crawled : 21:00) - prnewswire.com
NVO | $123.64 -0.21% 1.4M
|
Health Technology
|
| O: 0.09%
H: 1.41%
C: 0.94%
JNJ | $144.56 -2.05% 4.3M
|
Health Technology
|
| O: 0.67%
H: 0.56%
C: -0.01%
SNY | $46.19 0.57% 580K
|
Health Technology
|
| O: 0.51%
H: 0.0%
C: 0.0%
INCY | $53.88 0.84% 230K
|
Health Technology
|
| O: 0.48%
H: 1.39%
C: 0.51%
ALPN | $64.435 0.02% 800K
|
Health Technology
|
| O: -1.07%
H: 0.0%
C: -6.9%
bleeding disease market
Gainers vs Losers
| 51% | 49% |
Top 10 Gainers
WISA 4 | $7.86 349.14% 120M
|
Electronic Technology
TPET | $0.4951 114.24% 29M
|
n/a
PRSO | $1.99 56.69% 52M
|
Manufacturing
PALI | $6.5 56.25% 22M
|
Manufacturing
JAGX | $0.1767 48.74% 430M
|
Health Technology
SXTC | $2.03 45.0% 27M
|
Health Technology
DYNT | $0.5255 41.87% 18M
|
Health Technology
SPCB | $0.3888 40.87% 27M
|
Electronic Technology
SNGX | $0.54 39.86% 7.3M
|
Health Technology
MCBC | $13.795 38.92% 820K
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.